Increased plasma ApoA-I by ApoA-I infusion or transgenic expression of ApoA-I  were associated with increased plasma HDL-C and decreased atherosclerosis in experimental animal models [70–72]. The gene discussed is APOA1; the disease is atherosclerosis.